Protocol-directed weaning from mechanical ventilation: clinical outcome in patients randomized for a 30-min or 120-min trial with pressure support ventilation

2002 ◽  
Vol 28 (8) ◽  
pp. 1058-1063 ◽  
Author(s):  
Andreas Perren ◽  
Guido Domenighetti ◽  
Simonetta Mauri ◽  
Franco Genini ◽  
Nicoletta Vizzardi
2021 ◽  
Vol 15 (11) ◽  
pp. 2932-2933
Author(s):  
Khayyam Farid ◽  
Imran Ul Haq ◽  
Aqsa Saleema ◽  
Ambareen Sifatullah ◽  
Fazal Wfdood ◽  
...  

Aim: To compare pressure support versus T-piece trial for weaning from mechanical ventilation Methodology: Randomized clinical trial in Surgical ICU, Khyber Teaching hospital Peshawar. 48 patients who had been mechanically ventilated for at least 24 hours and were deemed suitable for weaning took part in the study. SBT with pressure support ventilation of 8cm of H2O was performed on one group of patients for two hours while the other group received a 30-minute SBT with pressure support ventilation. It was successful when extubation process is completed, (being able to go 72 hours without mechanical ventilation after the first SBT). Results: Extubation was successful in 83.3% who received pressure support ventilation and in 75% who employed a T-piece. The patients who required reintubation were 12% with support pressure and 16.7% with T piece ventilation. Mortality rate in support pressure group is 16.7% while 25% in T piece ventilation group. Conclusion: Pressure support ventilation for 30 minutes had a much higher success rate when it came to extubation. For spontaneous breathing trials, a shorter, less taxing ventilation approach should be used rather than the traditional one. Keywords: Extubation, Support pressure, T piece


Critical Care ◽  
2020 ◽  
Vol 24 (1) ◽  
Author(s):  
Liang-Jun Ou-Yang ◽  
Po-Huang Chen ◽  
Hong-Jie Jhou ◽  
Vincent Yi-Fong Su ◽  
Cho-Hao Lee

Abstract Background Pressure support ventilation (PSV) is the prevalent weaning method. Proportional assist ventilation (PAV) is an assisted ventilation mode, which is recently being applied to wean the patients from mechanical ventilation. Whether PAV or PSV is superior for weaning remains unclear. Methods Eligible randomized controlled trials published before April 2020 were retrieved from databases. We calculated the risk ratio (RR) and mean difference (MD) with 95% confidence intervals (CIs). Results Seven articles, involving 634 patients, met the selection criteria. Compared to PSV, PAV was associated with a significantly higher rate of weaning success (fixed-effect RR 1.16; 95% CI 1.07–1.26; I2 = 0.0%; trial sequential analysis-adjusted CI 1.03–1.30), and the trial sequential monitoring boundary for benefit was crossed. Compared to PSV, PAV was associated with a lower proportion of patients requiring reintubation (RR 0.49; 95% CI 0.28–0.87; I2 = 0%), a shorter ICU length of stay (MD − 1.58 (days), 95% CI − 2.68 to − 0.47; I2 = 0%), and a shorter mechanical ventilation duration (MD − 40.26 (hours); 95% CI − 66.67 to − 13.84; I2 = 0%). There was no significant difference between PAV and PSV with regard to mortality (RR 0.66; 95% CI 0.42–1.06; I2 = 0%) or weaning duration (MD − 0.01 (hours); 95% CI − 1.30–1.28; I2 = 0%). Conclusion The results of the meta-analysis suggest that PAV is superior to PSV in terms of weaning success, and the statistical power is confirmed using trial sequential analysis. Graphical abstract


Sign in / Sign up

Export Citation Format

Share Document